Kinase domain insert containing receptor promotor controlled suicide gene system kills human umbilical vein endothelial cells

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

290

HTML

2142

Figures (1-6)

267

Sum=2699

Jun 28, 2005 (publication date) through Nov 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jun 28, 2005; 11(24): 3686-3690
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3686

Full Size Figure Download Figure

Figure 5 Survival rate of transgeneic cells after prodrug administration.

Citation: Huang ZH, Yang WY, Cheng Q, Yu JL, Li Z, Tong ZY, Song HJ, Che XY. Kinase domain insert containing receptor promotor controlled suicide gene system kills human umbilical vein endothelial cells. World J Gastroenterol 2005; 11(24): 3686-3690
URL: https://www.wjgnet.com/1007-9327/full/v11/i24/3686.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i24.3686